Poster Abstract Session:
122. Antifungal Therapy
Saturday, October 22, 2011: 11:45 AM-1:45 PM
Room: Poster Hall B1

Topical Category: M. Mycology including clinical and basic studies of fungal infections

Tracks: Adult ID, Pediatric ID

Presentations:

882
A Pilot Study of an Over-the-Counter Mouthwash in the treatment of HIV-associated Oral Candidiasis
Joseph Masci, MD ; Maurice Policar, MD ; Pamela Gibbons, RN ; Geoffery Clover, MD

883
Outcome of Moderate-to-Severe Pneumocystis Pneumonia Treated with Adjunctive Steroid in Non-HIV-Infected Patients
Song Mi Moon, MD ; Tark Kim, MD ; Hyun Jung Park, MD ; So-Youn Park, MD ; Heungsup Sung, MD, PhD ; Mi-Na Kim, MD, PhD ; Sung-Han Kim, MD, PhD ; Sang-Ho Choi, MD, PhD ; Jin-Yong Jeong, PhD ; Jun Hee Woo, MD, PhD ; Yang Soo Kim, MD, PhD ; Sang-Oh Lee, MD

885
Voriconazole Therapeutic Drug Level Monitoring and Relation to Clinical Outcomes: Results from a Cohort Study
Helen Chu, MD ; Rupali Jain, PharmD ; Hu Xie, MSc ; Paul Pottinger, MD ; David Fredricks, MD

886
Anidulafungin (ANI) for Candidemia/Invasive Candidiasis (C/IC) in Intensive Care Unit (ICU) Patients (Pts) Post-Abdominal Surgery (Sx)
Philippe Montravers ; José Artur Paiva ; Wouter Meersseman ; Jan Pachl ; Ioana Grigoras ; Gabriele Sganga ; Francesco Menichetti ; Georgios Dimopoulos ; Georg Auzinger ; Marcio Borges Sá ; Paul Miller ; Tomás Marcek ; Michal Kantecki ; Markus Ruhnke

888
Renal Effects of Intravenous Voriconazole (V) vs. Fluconazole (F) and Caspofungin (C) in Patients with Compromised Renal Function
David Luke, PharmD ; Verna L. Welch, PhD, MPH ; Thomas Mayer, PhD ; Joanne Meisner, MPH ; Craig Lilly, MD

889
Voriconazole in Coccidioidal Meningitis following Failure of Response to Fluconazole
Arash Heidari, M.D. ; John Caldwell, Pharm.D. ; Aelita Chappell, M.D. ; Bahareh Ghafarizadeh, M.D. ; Royce H. Johnson, M.D., F.A.C.P.

892
Emergence of Hospital-Wide Triazole Resistant Candida glabrata Bloodstream Infections
Audrey N. Schuetz, MD, MPH ; Flonza Isovski, MD ; Rosemary Soave, MD ; David Helfgott, MD ; David P. Calfee, MD ; Stephen J. Wilson, MD, MPH ; Tsiporah Shore, MD ; Eric Feldman, MD ; Stephen Jenkins, PhD ; Thomas Walsh, MD, FIDSA

893
Initial Treatment Patterns and Antifungal Switching in Hospitalized Patients with Candidemia
Rolin Wade, RPh, MS ; Paresh Chaudhari, PharmD ; Rebecca Campbell, MD, MPH ; Harlen Hays, MPH ; Jing Yi, MA ; Smita Kothari, PhD, MBA, RPh ; David Horn, MD

896
Micafungin treatment and eradication of candiduria among hospitalized patients
Yoav Golan, MD MS ; Mihir Sura, MD ; Anisa Mohammed ; Spencer Martin, PharmD ; Steven Gabardi, PharmD

897
Assessment of the Influence of Timing of Antifungal (AF) Therapy on Outcomes in Candidemia
Thy Le, Pharm.D. ; Conan Macdougall, Pharm.D., MAS, BCPS ; Jason Gallagher, Pharm.D., B.C.P.S.

898
Treatment and Outcomes of Invasive Candidiasis at a Tertiary Care Center
Emily J Kuo, MPH ; Laura A. Puzniak, PhD, MPH ; Joshua A Doherty, BS ; Richard M. Reichley, PharmD ; Bernard C. Camins, MD, MSCR

899
Prophylaxis (Px) and Response to Treatment (Tx) of Invasive Mold Infections (IMI) in Hematopoeitic Cell Transplantation (HCT)
Jane Kriengkauykiat, PharmD ; Bernard Tegtmeier, PhD ; Sanjeet Dadwal, MD ; James Ito, MD

900
Differences in Nephrotoxicity as Measured by Serum Creatinine among Inpatients Treated with Liposomal Amphotericin B or Amphotericin B Lipid Complex
Rolin Wade, RPh, MS ; Paresh Chaudhari, PharmD ; Jaime Natoli, MS, MPH ; Robert Taylor ; Brian Nathanson, PhD ; Smita Kothari, PhD, MBA, RPh ; David Horn, MD

902
Evaluation of Invasive Fungal Infections in Preterm Neonates with and without Fluconazole Prophylaxis
Erin Senozan ; Murphy Steiner ; Xiang Fang, PhD ; John Schmidt, MD, MPH ; Brady Kerr, MD ; Meera Varman, MD

CME Credits:

ACPE Credits:

ACPE Number:


Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.